Search WLKP
Westlake Chemical Partners LP
NYSE · CIK 1604665
Last close21.27
Daily change+0.01 (0.05%)
10 Years gain+70.19%
Dividends TTM1.88 (+0.00%)
Dividend yield8.86%
Fundamental Analysis
WLKP · STANDARD
SIC 2860 · Industrial Organic Chemicals · Fiscal year end 1231
Fundamental
72.5Momentum
38.5Acceleration
38.5Confidence
76.0Annual Revenue12
Quarterly Revenue53
Annual CFO12
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth16.7 / 25
Quality17.2 / 25
Capital Efficiency20.0 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
No positive signals calculated.
Warnings
Gross margin compression · MEDIUMGross margin compressed by 2.6662 percentage points.
Operating margin compression · MEDIUMOperating margin compressed by 2.3035 percentage points.
Key Metrics
Revenue Growth TTM11.57%OK
Revenue CAGR 3Y67.06%OK
Gross Margin31.89%OK
Operating Margin29.54%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Yn/aINSUFFICIENT_HISTORY
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $1.17B | $347.85M | $319.58M | $280.47M | $201.65M | 29.81% | 27.39% | 17.28% | n/a | n/a |
| 2025 FY Dec 31, 2024 | $1.14B | $418.94M | $390.44M | $485.00M | $436.03M | 36.88% | 34.37% | 38.39% | n/a | n/a |
| 2025 FY Dec 31, 2023 | $1.19B | $387.46M | $357.71M | $452.00M | $405.18M | 32.54% | 30.04% | 34.03% | n/a | n/a |
| 2024 FY Dec 31, 2022 | n/a | $377.37M | $347.69M | $463.74M | $409.62M | n/a | n/a | n/a | n/a | n/a |
| 2022 FY Dec 31, 2022 | $250.24M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $1.21B | sum latest 4 fiscal quarters Revenue | OK | 0001604665-26-000027, 0001604665-25-000042 |
| Revenue Growth TTM | 11.57% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001604665-26-000027, 0001604665-25-000042 |
| Revenue CAGR 3Y | 67.06% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001604665-26-000010 |
| Revenue CAGR 5Y | 71.59% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001604665-26-000010 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | 0001604665-26-000010 |
| Operating Income Growth | 3.5% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001604665-26-000027, 0001604665-25-000042 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 31.89% | Gross Profit / Revenue | OK | 0001604665-26-000027, 0001604665-25-000042 |
| Operating Margin | 29.54% | Operating Income / Revenue | OK | 0001604665-26-000027, 0001604665-25-000042 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001604665-26-000027 |
| Current Ratio | 3.44x | Current Assets / Current Liabilities | OK | derived |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | 0001604665-26-000010 |
| Diluted EPS TTM | n/a | Net income TTM / Diluted shares | NOT_MEANINGFUL | 0001604665-26-000027, 0001604665-25-000042 |